Evidence map›Paper›PMID 26585883›Full record

ArticleContraception2016

Engineering and characterization of simplified vaginal and seminal fluid simulants.

Rachna Rastogi, Jonathan Su, Alamelu Mahalingam, Justin Clark, Samuel Sung, Thomas Hope, Patrick F Kiser

Abstract read
In one paragraph

Article in Contraception, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Fiber-Reinforced Composites for Vaginal Tissue Engineering Applications.Journal of biomedical materials research. Part A · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Comparative genome analyses ofApplied and environmental microbiology · 2021
    Article
  13. ClinicalmSphere · 2020
    Article
  14. Article
  15. Comparative Analysis ofFrontiers in microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rachna RastogiDepartment of Bioengineering, University of Utah, Salt Lake City, UT, USA.
Jonathan SuDepartment of Biomedical Engineering, Northwestern University, Evanston, IL, USA.
Alamelu MahalingamDepartment of Bioengineering, University of Utah, Salt Lake City, UT, USA.
Justin ClarkDepartment of Biomedical Engineering, Northwestern University, Evanston, IL, USA.
Samuel SungDepartment of Biomedical Engineering, Northwestern University, Evanston, IL, USA.
Thomas HopeCell and Molecular Biology Department, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Patrick F KiserDepartment of Bioengineering, University of Utah, Salt Lake City, UT, USA; Department of Biomedical Engineering, Northwestern University, Evanston, IL, USA; Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. Electronic address: patrick.kiser@northwestern.edu.

Funding

Sustained Intravaginal Delivery Technologies Against HIV and HSVU19AI076980 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI HEROLD, BETSY C. · 2009 to 2012
$10.1M
NIAID NIH HHS U19 AI076980NIAID NIH HHS U19AI076980
6 · The paper itself

Abstract

backgroundReported vaginal and seminal fluid simulants have complex compositions with multiple preparatory steps that contribute to physical instability. We report the design and characterization of stable and simplified buffers that mimic the salient physical/chemical properties of the physiological fluids. STUDY DESIGN/

methodsHuman cervicovaginal and seminal fluid samples were collected and buffering capacity was determined. The major buffering species were identified from published compositions of reproductive tract fluids. These values were used to compute the composition of vaginal and seminal fluid simulants. Ionic strength, buffering capacities, pH and osmolalities were then calculated or experimentally determined. Finally, cytotoxicity was evaluated in HEC-1-A cells and 3D reconstructed EpiVaginal™ tissue (VEC-100-FT) using naïve cells/tissue and nonoxynol-9 as controls.

resultsThe use of calculated amounts of conjugate acid and base for buffer development resulted in compositions that did not require endpoint pH adjustment and could be formulated as stable 10× concentrates. Furthermore, due to the absence of complex divalent salts, all our proposed simulants were stable at 4 °C for 1 month whereas precipitation and pH and osmolality changes were noted in reported buffers. Experimental determination of buffering capacities yielded similar values for undiluted cervicovaginal fluid (β4.2-5.2=35.6 ± 12.3 mM, N=7) and human seminal fluid (β7-6=37.5 ± 5 mM, N=3). All neat simulants showed significant cytotoxicity in HEC-1-A cells but were well tolerated by organotypic vaginal tissue.

conclusionsWe report revised and improved compositions of buffers mimicking salient properties of vaginal and seminal fluid necessary for in vitro product evaluation. IMPLICATIONS: To support research in reproductive health and in particular drug delivery, we have designed and characterized stable new media to mimic these important fluids that can be used in a variety of in vitro studies.

Indexed as

VaginaBioengineeringBody FluidsBuffersChemical PhenomenaChemical PrecipitationDrug Delivery SystemsFemaleHumansHydrogen-Ion ConcentrationMaleOsmolar ConcentrationSemenBuffersBuffering capacityCytotoxicityHuman cervicovaginal fluidSimulant design

Identifiers

PMID26585883
PMCPMC4863460

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.